(276 days)
The Isolette® 8000 plus incubator is indicated for thermoregulation and controlling oxygen (optional), and humidity (optional) for both premature and full-term infants up to a maximum of 10 kg (22lbs).
The Isolette® 8000 plus is not intended for home use.
The Isolette 8000 plus is a device used to maintain environmental conditions suitable for neonates. The Isolette 8000 plus incubator provides a controlled environment for both premature and full-term infants up to a maximum of 10 kg (22lbs). It controls temperature, oxygen (optional) and humidity (optional). It is a controller-based incubator featuring the ability to enable simultaneous control of temperature, and optional oxygen and humidity. The system operates on AC power. Data is provided on a liquid crystal display. It is operated in closed care therapy as an incubator according to IEC60601-2-19.
Components include hand ports or iris ports, access panel, serial port, trolley with height adjustment, castor wheels with brakes, power receptacle, a Trendelenburg bed-tilt mechanism (0° to 12°), softbed mattress, skin temperature probes, probe covers, oxygen inlet, sensor module, hose grommets, accessoryrail and cable wrap. Optional components include IV pole, drawers, water reservoir, collection bottler mount litter bag holder, basket for gloves, breathing hose holder kit, tray, high frequency ventilation (HFV) door with grommets, positioning aids, incubator cover, and monitor shelf.
The provided text describes the regulatory clearance of the Isolette® 8000 plus neonatal incubator and its comparison to a predicate device (Isolette® Infant Incubator, Model C2HS, K001242) for showing substantial equivalence. It does not contain information about an AI-powered device or a study involving human experts or a training set for machine learning. Therefore, many of the requested details are not applicable as this is a traditional medical device submission without AI.
However, based on the provided text, I can extract the acceptance criteria and a summary of the non-clinical studies performed to demonstrate that the device meets those criteria.
Acceptance Criteria and Device Performance for Isolette® 8000 plus (K172154)
This submission is for a traditional medical device (neonatal incubator) and does not involve AI. Therefore, numerous requested sections related to AI performance, human expert evaluation, and training sets are not applicable.
1. A table of acceptance criteria and the reported device performance
The acceptance criteria are generally implied by the stated specifications and compliance with recognized standards. The "Device Under Review" column effectively serves as the reported device performance compared to the predicate.
| Specification (Acceptance Criterion implied by predicate/standards) | Predicate (Isolette® Infant Incubator, Model C2HS) Performance | Device Under Review (Isolette® 8000 plus) Performance | Comments (Device Meets or is Similar to Predicate) |
|---|---|---|---|
| Intended Use | Care for premature and full-term babies, controlled environment in NICU/Special Care Baby Unit etc. | Controlled environment for premature and full-term infants up to 10 kg (22lbs). Controls temperature, oxygen (optional), and humidity (optional). Not for home use. | Same - Wording different, but intended use unchanged. |
| Indications for Use | Effective temperature management, reduces radiant heat loss, minimizes evaporative heat loss, monitors/maintains O2 levels. | Thermoregulation and controlling oxygen (optional), and humidity (optional) for premature and full-term infants up to 10 kg (22lbs). Not for home use. | Similar - Simplified wording; functional indications unchanged; similar technology. |
| Target Population | Premature and full term infants | Newly born infants up to 10 kg (22lbs) | Same - Weight added as information. |
| Environment of Use | NICU/Special Care Baby Unit, Step Down Nursery, Newborn Nursery and pediatrics. | Any department of the hospital that provides neonatal and infant care, including NICU/Special Care Baby Unit, Step Down Nursery, Newborn Nursery and pediatrics. | Similar - Broader phrasing for hospital areas. |
| Principle of Operation | Controller-based incubator, simultaneous control of temp, O2, humidity. | Same as C2HS | Same |
| Protection Class | Class I, Type BF, continuous, not AP | Same as C2HS | Same |
| Ingress of liquids and particulate matter (IEC 60601-1) | IPXO | Same as C2HS | Same |
| Height | 133.4-152.4 cm (52.5-60 in) | 133.3 to 153.7 cm (52.5 to 60.5 in) | Similar - No effect on function. |
| Width | 99 cm (38.0 in) | <104 cm (41 in) | Similar - No effect on function. |
| Depth | 59.7 cm (23.5in) | <76.2 cm (30 in) | Similar - No effect on function. |
| Weight | 99 kg (198 lb.) | <98.5 kg (217.1 lb.) without options/accessories | Similar - No effect on function. |
| Mattress size | 40.6 x 78.7cm(16 x 31.5 in) | >38 x 74 x3 cm (15 x 29.1 x 1.2 in) | Similar - No effect on function. |
| Trendelenburg/Reverse Trendelenburg | Continuously variable to 12 deg. +1 deg. | Same as C2HS | Same |
| Infant Weight | Not published | 10 kg (22 lbs.) maximum | Same - Specification not previously published. |
| Operating temperature | 20-30°C (68-86°F) | Same as C2HS | Same |
| Operating humidity | 5-99% RH non-condensing | 5-95% RH non-condensing | Similar |
| Operating altitude | 3048m (10,000 ft.) | Up to 3000 m (9800 ft.) | Similar - Meets IEC 60601-1. |
| Operating Ambient air pressure | Not available | 110-70 kPa | Same - Design elements unchanged. |
| Storage temperature | -30 to 70°C (-22 to 158°F) | -20 to 60°C (-4 to 140°F) | Similar - Device packaging marked with requirements. |
| Storage humidity | 0-99% RH, non-condensing | 5-95% RH non-condensing | Similar |
| Storage Ambient air pressure | Not available | 110-50 kPa | Same - Design elements unchanged. |
| Power req. 100/120V | 100/120V ± 10%, 50/60 Hz, 1900 W max. | 100/120V, 50/60 Hz, 1900 W max, 9.9 A max | Similar - Amperage added; not clinically relevant. |
| Auxiliary power sockets | All 50/60 Hz, 100, 120, 220, & 240V ± 10% 500W max. | All 50/60 Hz, 100 V, 100W max; 120 & 230 V 300W max | Similar - Both meet current safety standards. |
| Earth Leakage | < 300µA 100 & 120V; < 500µA 220 & 240V | < 500 µA | Similar - Both meet current safety standards. |
| Air temperature mode - Set point range | 20-37°C (68-98.6°F) | 20 to 39°C (68-102.2°F) | Same - I8000 plus publishes entire range. |
| Control override range | 37-39°C (98.6-102.2 F) | Same as C2HS | Same |
| Set point display range | 15 to 45°C (59-113 F) | Same as C2HS | Same |
| Upwards deviation limit | Fixed +1.5°C | +1.5 to +2.5°C (+2.7 to 4.5°F) | Similar - I8000 plus allows adjustment. |
| Upwards deviation limit default | Fixed +1.5°C | +1.5°C (+2.7°F) | Similar - Default value is same. |
| Downwards deviation limit range | Fixed -2.5°C | -1.5 to -2.5°C (-2.7 to-4.5F) | Similar - I8000 plus allows adjustment. |
| Downwards deviation limit default | Fixed -2.5°C | -2.5°C (-4.5F) | Similar - Default value is same. |
| Warm-up time at 22°C (72°F) ambient | <35min | Same as C2HS | Same |
| Variability | <0.5°C (<0.9°F) | Same as C2HS | Same |
| Overshoot | <0.5°C (<0.9°F) | Same as C2HS | Same |
| Uniformity with a level mattress | <0.8°C (<1.4°F) | Same as C2HS | Same |
| Skin Temperature Mode - Set point range | 34.0 to 37.0°C (93.2 to 98.6°F) | Same as C2HS | Same |
| Control override temp range | 37.0 to 38.0°C (98.6 to 100.4°F) | Same as C2HS | Same |
| Set point display range (skin temp) | 15.0 to 45.0°C (59 to 113°F) | Same as C2HS | Same |
| Accuracy of incubator temp indication | ≤0.8°C | Same as C2HS | Same |
| Deviation limit range (skin temp) | 0.5 to 1.0°C | 0.3 to 1.0°C (0.5 to 1.8°F) | Similar - I8000 plus has tighter limit. |
| Deviation limit default (skin temp) | 1.0°C (1.8°F) | Same as C2HS | Same |
| Kangaroo Mode | No | Yes | Different - New feature, details tested. |
| Noise level within the hood environment | ≤47 dB(A) w/ 37 dB(A) or less ambient | Same as C2HS | Same |
| Air velocity over the mattress | <10 cm/second (4 in/second); average of 5 points at 10cm (4 in) above the mattress | Same as C2HS | Same |
| Carbon Dioxide (CO2) level (per IEC60601-2-19, clause 105) | <0.8% | Same as C2HS | Same |
| Oxygen deviation limit range | 3% fixed | 3% to 5% | Similar - User-adjustable to reduce nuisance alarms. |
| Oxygen deviation limit default | 3% | Same as C2HS | Same |
| Set point data retention (power failure) | <10 min | Same as C2HS | Same |
| Acoustical level (all alarms on) | 75 dB(A) maximum | Same as C2HS | Same |
| External Communication - Type | 9-pin Sub-D (female), electrically isolated Protocol | Same as C2HS | Same |
| Configurations | Serial Data Output | Serial Data Output (default) or MEDIBUS.X | Similar - MEDIBUS.X addition not clinically relevant. |
| Baud rate (Serial Data Output) | 2400 | Same as C2HS | Same |
| Humidification system | Manual adjustment of humidity setpoints | Automatic based on user setpoint (Autohumidity) | Similar - Both provide humidity control. |
| Humidity control duration of operation after refilling | >24 hours @ 85% RH and 37°C, in air temp mode | Same as C2HS | Same |
| Humidity control reservoir capacity | 1000 mL | 1500 mL | Similar - Difference not clinically relevant. |
| Humidity control range | 30% to 95% in 1% increments | Same as C2HS | Same |
| Humidity control accuracy (10-90% @ 20-40°C) | ±5% RH | ±6% RH | Similar - 1% difference not clinically relevant. |
| Oxygen control range | 21% to 65% | Same as C2HS | Same |
| Oxygen display accuracy (100% calibration) | ±3% | Same as C2HS | Same |
| Material used for direct patient contact | Textile Polyurethane, PVC, Hydrogel | Textile Polyurethane, TPE, Hydrogel | Similar - TPE material tested for biocompatibility. |
| Biocompatibility | According to ISO 10993 | Same as C2HS | Same |
| Thermonitoring | N/A - only displays skin temperature | Trend display of difference between central and peripheral skin temperatures | Similar. Isolette 8000 plus provides additional trend info. |
2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
This information is not provided in the document. The studies were non-clinical bench testing, not clinical studies involving patient data.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
Not applicable. This is a non-AI medical device submission, and the ground truth was established through engineering specifications, regulatory standards compliance, and bench testing, not human expert interpretation of data.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable. This is a non-AI medical device submission.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This is a non-AI medical device submission.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This is a non-AI medical device submission. The device performs as a standalone incubator without human-in-the-loop performance in the context of an AI algorithm; however, human operators are inherently part of its use.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
The "ground truth" for this device is based on engineering specifications, recognized international standards (e.g., IEC 60601-1, IEC 60601-2-19, IEC 60601-1-2, ISO-10993), and internal design control procedures. Performance benchmarks are set by these standards and the predicate device's capabilities.
8. The sample size for the training set
Not applicable. This is a non-AI medical device submission; there is no "training set" in the machine learning sense.
9. How the ground truth for the training set was established
Not applicable.
Summary of Studies to Prove Acceptance Criteria are Met (Non-Clinical Testing):
The Isolette® 8000 plus underwent a series of non-clinical bench tests and evaluations to demonstrate its safety and effectiveness and substantial equivalence to the predicate device. These include:
- Performance Testing: Conducted in accordance with applicable standards and technical system requirements, as well as the device's Instructions for Use (IFU) Technical Data Section. This covers all the operational specifications listed in the table above (e.g., temperature control ranges, humidity accuracy, oxygen control, noise levels, warm-up times).
- Electrical Safety and Electromagnetic Compatibility (EMC): Compliance with IEC 60601-1, IEC 60601-2-19 (safety and performance), and IEC 60601-1-2 (EMC).
- Software Verification and Validation Testing: Conducted following FDA guidance for medical device software. The software was considered a "major" level of concern.
- Biocompatibility Testing: Conducted in accordance with FDA guidance on ISO 10993 standards. Tests included:
- Integral Test for volatile organic compounds
- Photogenic bacteria test
- Emission of particles
- Material characterization (ISO 10993-18)
- Toxicological Evaluation (ISO 10993-17)
- Cytotoxicity
- Irritation
- Sensitization
- Human Factors: Usability evaluation conducted in accordance with FDA guidance on Human Factors and Usability Engineering.
- Reprocessing: Assessed following FDA guidance ("Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling").
- Cleaning/Disinfection: Macroscopic and microbiological validation performed with Oxycide by an accredited laboratory (DIN EN ISO/IEC 17025).
- Kangaroo Mode Performance Testing: Performed according to the technical requirements for this new feature.
- Autohumidity Performance Testing: Performed according to technical requirements for the optional humidification system.
- Thermomonitoring Performance Testing: Performed according to technical requirements.
- External Communication (Serial data output or Medibus X) Performance Testing: Performed according to technical requirements.
- Trendelenburg (Tilt Mechanism) Regression Testing: Performed for mechanical changes compared to the predicate device.
No animal or clinical studies were conducted for this submission. The conclusion drawn from these non-clinical studies was that the Isolette® 8000 plus meets performance requirements and standards and is substantially equivalent to the predicate device K001242.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The FDA logo is composed of two parts: the Department of Health and Human Services logo on the left and the FDA acronym and full name on the right. The Department of Health and Human Services logo is a stylized representation of a human figure, while the FDA acronym and full name are written in blue.
April 19, 2018
Dräger Medical Systems, Inc. Gale Winarsky Manager, Regulatory Affairs 3135 Quarry Road Telford. Pennsylvania 18969
Re: K172154
Trade/Device Name: Isolette® 8000 plus Regulation Number: 21 CFR 880.5400 Regulation Name: Neonatal Incubator Regulatory Class: Class II Product Code: FMZ Dated: March 16. 2018 Received: March 19, 2018
Dear Gale Winarsky:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
{1}------------------------------------------------
801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Geeta K. Pamidimukkala -S
for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K172154
Device Name Isolette® 8000 plus
Indications for Use (Describe)
The Isolette® 8000 plus incubator is indicated for thermoregulation and controlling oxygen (optional), and humidity (optional) for both premature and full-term infants up to a maximum of 10 kg (22lbs).
The Isolette® 8000 plus is not intended for home use.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) | |
| ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the word "Dräger" in a bold, sans-serif font. The word is a dark blue color. The two dots above the "a" are also dark blue. The word is centered in the image.
510(k) Summary K172154
| Manufacturer Name and Address: | Dräger Medical Systems, Inc.3135 Quarry RoadTelford, PA 18969 |
|---|---|
| Contact Person: | Gale WinarskyManager, Regulatory AffairsPhone: 215-660-2239Fax: 215-721-5424 |
| Date summary was prepared: | 2018-04-19 |
| Device Name: | Trade Name: Isolette® 8000 plusClassification Name: Neonatal Incubator |
Legally Marketed Device Identification: Substantial equivalence is claimed to the legally marketed predicate; Isolette Infant Incubator, Model C2HS, K001242.
21 CRF 880.5400
FMZ
DeviceDescription:
The Isolette 8000 plus is a device used to maintain environmental conditions suitable for neonates. The Isolette 8000 plus incubator provides a controlled environment for both premature and full-term infants up to a maximum of 10 kg (22lbs). It controls temperature, oxygen (optional) and humidity (optional). It is a controller-based incubator featuring the ability to enable simultaneous control of temperature, and optional oxygen and humidity. The system operates on AC power. Data is provided on a liquid crystal display. It is operated in closed care therapy as an incubator according to IEC60601-2-19.
Components include hand ports or iris ports, access panel, serial port, trolley with height adjustment, castor wheels with brakes, power receptacle, a Trendelenburg bed-tilt mechanism (0° to 12°), softbed mattress, skin temperature probes, probe covers, oxygen inlet, sensor module, hose grommets, accessoryrail and cable wrap. Optional components include IV pole, drawers, water reservoir, collection bottler mount litter bag holder, basket for gloves, breathing hose holder kit, tray, high frequency ventilation (HFV) door with grommets, positioning aids, incubator cover, and monitor shelf.
Indications for Use:
The Isolette® 8000 plus incubator is indicated for thermoregulation and controlling oxygen (optional), and humidity (optional) for both premature and full-term infants up to a maximum of 10 kg (22lbs).
The Isolette® 8000 plus is not intended for home use.
Regulation Number:
Product Code:
Class:
{4}------------------------------------------------
Comparison of Technological Characteristics with Predicate Device:
| Specification | Predicate | Device Under Review | Comments |
|---|---|---|---|
| Device Name | Isolette® Infant Incubator, Model C2HS | Isolette®8000 plus (I8000 plus) | |
| Manufacturer | Hill-Rom Air-Shields | Draeger Medical Systems, Inc. | |
| 510(k) | K001242 | K172154 | |
| Regulation # | 880.5400 | 880.5400 | |
| Product Code | FMZ | FMZ | |
| Classification | II | II | Same |
| UMDNS/GMDNS code | 12-113/36025 | 12-113/36025 | Same |
| Standards | 60601-1; 60601-1-2; 60601-2-19 | 60601-1; 60601-1-2; 60601-2-19 | Same |
| Intended Use | Designed to care for the smaller prematurebaby as well as the healthier full termbaby. It does this by providing a controlledenvironment, one in which the baby can beprovided with the necessary care as wellas being left undisturbed in the security ofthe incubator.It is to this end that the product can beused in any department of the hospital thatprovides neonatal and infant care. Onewould typically expect the Isolette to beused in the NICU/Special Care Baby Unit.The design lends itself to all levels of carein the NICU making it suitable for use inlevel I, II, III, and IV where applicable.Other departments would include the StepDown Nursery, Newborn Nursery andpediatrics. | The Isolette® 8000 plus incubatorprovides a controlled environment forboth premature and full-term infants upto a maximum of 10 kg (22lbs). Itcontrols temperature, oxygen (optional)and humidity (optional). | Same - While the wording is different, theintended use of the I8000 plus has notchanged from the predicate C2HS. Bothdevices are incubators, both provide acontrolled environment, both are used for thesame patient population.The patient population has not changed fromthe predicate. The weight is now provided inas additional information for the user. |
| Specification | Predicate | Device Under Review | Comments |
| Device Name | Isolette® Infant Incubator, Model C2HS | Isolette®8000 plus (I8000 plus) | |
| Indications for Use | Effective temperature management isImperative to the development of thepremature baby. The Isolette® InfantIncubator incorporates a uniquebidirectional air flow to help reduce radiantheat loses from the infant by warming theinner hood surface. The Hill-Rom Air-Shields patented Air Curtain has beenincorporated into the Isolette InfantIncubator to reduce temperaturefluctuations within the incubator when theaccess panels are opened. With theHumidity module installed, operationalevaporative heat losses are minimized.With the installation of the optional Oxygencontrol system, the Oxygen level within theinfant compartment can be monitored andmaintained. | The Isolette® 8000 plus incubator isindicated for thermoregulation andcontrolling oxygen (optional), andhumidity (optional) for both prematureand full-term infants up to a maximumof 10 kg (22lbs).The Isolette® 8000 plus is not intendedfor home use. | Similar - While the indications statement hasbeen simplified, substantial equivalence issupported by the following:The functional indications for use for the I8000plus have not changed from the C2HS. Bothdevices provide temperature management.This wording has been simplified in the I8000plus Indications by using the term"thermoregulation", which by definition meanstemperature control.Both devices use the same air flow and "AirCurtain' technology for thermoregulation.Both devices offer humidity, and oxygencontrol used for the same applications.Both devices have the same environment ofuse.Neither device is intended for home use. |
| TargetPopulation/PatientPopulation | Premature and full term infants | Newly born infants up to 10 kg. (22lbs) | Same - The patient population has notchanged from the predicate. The weight ofthe patient is now provided as additionalinformation for the user. |
| Environment of Use | Isolette to be used in the NICU/SpecialCare Baby Unit and the Step DownNursery, Newborn Nursery and pediatrics. | The I8000 plus can be used in anydepartment of the hospital that providesneonatal and infant care, includingNICU/Special Care Baby Unit and theStep Down Nursery, Newborn Nurseryand pediatrics. | Similar - Some hospitals may refer to theirneonatal and infant care areas by other termsthan NICU, Step Down Nursery, NewbornNursery and pediatrics. |
| System Specifications | |||
| Principle of Operation | Controller-based incubator that enablessimultaneous control of temperature,oxygen, and humidity parameters affectingthe infant | Same as C2HS | Same |
| Specification | Predicate | Device Under Review | Comments |
| Device Name | Isolette® Infant Incubator, Model C2HS | Isolette®8000 plus (I8000 plus) | |
| Protection class | Class I, Type BF, continuous operation, not AP | Same as C2HS | Same |
| Ingress of liquids and particulate matter (IEC 60601-1) | IPXO | Same as C2HS | Same |
| Physical Attributes | |||
| Height | 133.4-152.4 cm (52.5-60 in) | 133.3 to 153.7 cm (52.5 to 60.5 in) | Similar - No effect on function |
| Width | 99 cm (38.0 in) | <104 cm (41 in) | Similar - No effect on function |
| Depth | 59.7 cm (23.5in) | <76.2 cm (30 in) | Similar - No effect on function |
| Weight | 99 kg (198 lb.) | <98.5 kg (217.1 lb.) without options/accessories | Similar - No effect on function |
| Mattress size | 40.6 x 78.7cm(16 x 31.5 in) | >38 x 74 x3 cm (15 x 29.1 x 1.2 in) | Similar - No effect on function |
| Trendelenburg/Reverse Trendelenburg | Continuously variable to 12 deg. +1 deg. | Same as C2HS | Same |
| Infant Weight | Not published | 10 kg (22 lbs.) maximum | Same - Specification not previously published. |
| Environmental | |||
| Operating temperature | 20-30C (68-86 F) | Same as C2HS | Same |
| Operating humidity | 5-99% RH non-condensing | 5-95% RH non-condensing | Similar |
| Operating altitude | 3048m (10,000 ft.) | Up to 3000 m (9800 ft.) | Similar - 3000 m meets the criteria from IEC 60601-1 and internal requirements. |
| Operating Ambient air pressure | Not available | 110-70 kPa | Same - Operating ambient air pressure is not documented for the predicate. The incubator design elements related to the ambient air pressure have not changed from C2HS predicate to the I8000 plus. |
| Storage temperature | -30 to 70 deg. C (-22 to 158 deg. F) | -20 to 60 deg. C (-4 to 140 deg. F) | Similar - Device packaging is marked with storage temperature requirements |
| Storage humidity | 0-99% RH, non-condensing | 5-95% RH non-condensing | Similar |
| Storage Ambient air pressure | Not available | 110-50 kPa | Same - Only the operating altitude is available for the predicate. The incubator design elements related to the ambient air pressure have not changed from C2HS predicate to the I8000 plus. |
| Specification | Predicate | Device Under Review | Comments |
| Device Name | Isolette® Infant Incubator, Model C2HS | Isolette®8000 plus (I8000 plus) | |
| ElectricalRequirements | |||
| Power req. 100/120V | 100/120V $\pm$ 10%, 50/60 Hz, 1900 W max. | 100/120V, 50/60 Hz, 1900 W max, 9.9 Amax | Similar - Amperage was not applicable to theC2HS as it had a circuit breaker instead offuse. Not clinically relevant. |
| Auxiliary power sockets | All 50/60 Hz100, 120, 220, & 240V $\pm$ 10% 500W max. | All 50/60 Hz100 V, 100W max120 & 230 V 300W max | Similar - Both meet current safety standards. |
| Earth Leakage | < 300μA 100 & 120V< 500μA 220 & 240V | < 500 µA | Similar - Both meet current safety standards. |
| General Performance | |||
| Air temperature mode | |||
| Set point range | 20-37 C (68-98.6 F) | 20 to 39 C (68-102.2 F) | Same - Both devices have a range of 20-39 C(68-102.2 F). The I8000 plus publishes theentire range including the Control OverrideRange from 37-39 C, rather than just thegeneral range as published by the C2HS 20-37C. |
| Control override range | 37-39 C ( 98.6- 102.2 F) | Same as C2HS | Same |
| Set point display range | 15 to 45 C (59-113 F) | Same as C2HS | Same |
| Upwards deviation limit | Fixed +1.5 | +1.5 to +2.5 C (+2.7 to 4.5 F) | Similar - Both devices have an airtemperature deviation limit. The I8000 plusallows the user to adjust the deviation rangefor the set point at which an alarm willactivate. |
| Upwards deviation limitdefault | Fixed +1.5 | +1.5 C (+2.7 F) | Similar - Default value is the same |
| Downwards deviationlimit range | Fixed -2.5C | -1.5 to -2.5C (-2.7 to-4.5F) | Similar - Both devices have an airtemperature deviation limit. The I8000 plusallows the user to adjust the deviation rangefor the set point at which an alarm willactivate. |
| Downwards deviationlimit default | Fixed -2.5 | -2.5C (-4.5F) | Similar - Default value is the same |
| Warm-up time at 22C(72F) ambient | <35min | Same as C2HS | Same |
| variability | <0.5C (<0.9F) | Same as C2HS | Same |
| Specification | Predicate | Device Under Review | Comments |
| Device Name | Isolette® Infant Incubator, Model C2HS | Isolette®8000 plus (I8000 plus) | |
| overshoot | <0.5C (<0.9F) | Same as C2HS | Same |
| Uniformity with a levelmattress | <0.8C (<1.4F) | Same as C2HS | Same |
| Skin TemperatureMode | |||
| Set point range | 34.0 to 37.0C (93.2 to 98.6F) | Same as C2HS | Same |
| Control override temprange | 37.0 to 38.0C (98.6 to 100.4F) | Same as C2HS | Same |
| Set point display range | 15.0 to 45.0C (59 to 113F) | Same as C2HS | Same |
| Accuracy of incubatortemp indication | ≤0.8C | Same as C2HS | Same |
| Deviation limit range | 0.5 to 1.0C | 0.3 to 1.0C (0.5 to 1.8F) | Similar - the I8000 plus has a tighter limit |
| Deviation limit default | 1.0C (1.8F) | Same as C2HS | Same |
| Specification | Predicate | Device Under Review | Comments |
| Device Name | Isolette® Infant Incubator, Model C2HS | Isolette®8000 plus (I8000 plus) | |
| Kangaroo Mode | No | Yes | Different - The C2HS does not includeKangaroo Mode. Kangaroo Care iscommonly used in neonatal care to allowskin to skin contact between the patient andparent/caregiver. The features of KangarooMode are provided under the Discussion ofNon-Clinical Testing. |
| Misc. Specifications | |||
| Noise level within thehood environment | ≤47 dB(A) w/ 37 dB(A) or less ambient(w/out servo O2 control) | Same as C2HS | Same |
| Air velocity over themattress | <10 cm/second (4 in/second); average of5 points at 10cm (4 in) above the mattress | Same as C2HS | Same |
| Carbon Dioxide (CO2)level (per IEC60601-2-19, clause 105) | <0.8% | Same as C2HS | Same |
| Oxygen deviation limitrange | 3% fixed | 3% to 5% | Similar - In the I8000 plus the alarm limitdeviation can be adjusted by the user tominimize nuisance alarms. |
| Oxygen deviation limitdefault | 3% | Same as C2HS | Same |
| Set point data retention | Power failures lasting <10 min | Same as C2HS | Same |
| Acoustical level (allalarms on) | 75 dB(A) maximum | Same as C2HS | Same |
| ExternalCommunication | |||
| COM port (output only) | Only connects to devices that fulfill therequirements of the standard IEC 60950-1on unearthed SELV circuits or therequirements of the standard IEC 60601-1on accessible secondary circuits with max.60 V DC nominal voltage. | Same as C2HS | Same |
| Specification | Predicate | Device Under Review | Comments |
| Device Name | Isolette® Infant Incubator, Model C2HS | Isolette®8000 plus (I8000 plus) | |
| Type | 9-pin Sub-D (female), electrically isolatedProtocol | Same as C2HS | Same |
| Configurations | Serial Data Output | Serial Data Output (default) orMEDIBUS.X | Similar - The addition of Medibus.X as analternate for the output of data is not clinicallyrelevant to the function of the incubator. |
| Serial data output | |||
| Baud rate | 2400 | Same as C2HS | Same |
| Parity | None | Same as C2HS | Same |
| Data bits | 8 | Same as C2HS | Same |
| Stop bits | 1 | Same as C2HS | Same |
| Draeger MEDIBUS.X,version 6 | By the RS-232 port only | Same as C2HS | Same |
| Baud rate | 9600 | Same as C2HS | Same |
| Parity | Even | Same as C2HS | Same |
| Data bits | 8 | Same as C2HS | Same |
| Stop bits | 1 | Same as C2HS | Same |
| Pin assignment | Same | ||
| Pin 2 | RXD | Same as C2HS | Same |
| Pin 3 | TXD | Same as C2HS | Same |
| Pin 5 | GND | Same as C2HS | Same |
| Humidification system(option) | Manual adjustment of humidity setpoints | Automatic based on user setpoint(Autohumidity) | Similar - Both provide humidity control |
| Humidity control durationof operation after refilling | >24 hours @ 85% RH and 37 deg. C, in airtemp mode | Same as C2HS | Same |
| Humidity controlreservoir capacity | 1000 mL | 1500 mL | Similar - The difference in reservoir capacityis not clinically relevant. |
| Humidity control range | 30% to 95% in 1% increments (at highambient humidity levels, low-level humiditysettings may not be attainable) | Same as C2HS | Same |
| Humidity controlaccuracy between 10%and 90% @ 20 to 40C(68 to 104F) | ±5% RH | ±6% RH | Similar - The difference in the humiditycontrol of 1% is not clinically relevant |
| Humidity display range | 10% to 100% | Same C2HS | Same |
| Maximum humidity levels | >85% (incubator set temp at 39C with at | Same C2HS | Same |
| Specification | Predicate | Device Under Review | Comments |
| Device Name | Isolette® Infant Incubator, Model C2HS | Isolette®8000 plus (I8000 plus) | |
| least 30% RH at ambient) | |||
| Oxygen control system(option) | |||
| Servo oxygen controlsystem (option) | Yes | Same C2HS | Same |
| Oxygen inlet pressure | 40 to 150 psi (2.8 kg/cm2 to 10.5 kg/cm2) | Same as C2HS | Same |
| Oxygen inlet flow rate | 30 L/min | Same as C2HS | Same |
| Oxygen control range | 21% to 65% | Same as C2HS | Same |
| Oxygen displayresolution | 1% | Same as C2HS | Same |
| Oxygen display accuracy(100% calibration) | ±3% | Same as C2HS | Same |
| Oxygen display accuracy(21% calibration) | ±5% | Same as C2HS | Same |
| Oxygen display range | 18% to 100% | Same as C2HS | Same |
| Oxygen control accuracy | ±2% of full scale | Same as C2HS | Same |
| Manual oxygen controlsystem (option) | |||
| Oxygen inlet pressure | 40psi to 150 psi (2.8 kg/cm² to 10.5kg/cm²) | Same as C2HS | Same |
| Oxygen inlet flow rate | 30 L/min | Same as C2HS | Same |
| Weighing System | |||
| Standard weighingsystem (accessory) | |||
| Weight display range | 0 kg (0 lb.) to 7 kg (15.4 lbs.) | Same as C2HS | Same |
| Weight display resolution | 1 g or 1oz | Same as C2HS | Same |
| Weight display accuracy | 0 to 2 kg: ±2 g (0 to 4.4 lb.: ±0.07 oz.) | Same as C2HS | Same |
| > 2 kg: ±5 g (>4.4 lb.: ±0. 18 oz.) | |||
| Tare weight | 4±0.5kg | ≤4.0 kg (8.82 lb.) | Same |
| OIML weighing system(accessory) | OIML weighing system is only for EUcountries requiring a scale that complies withthe NAWI directive. | ||
| Material - no implants | |||
| Specification | Predicate | Device Under Review | Comments |
| Device Name | Isolette® Infant Incubator, Model C2HS | Isolette®8000 plus (I8000 plus) | |
| Material used for indirectpatient contact | Metal (e.g. Aluminum) Synthetic material(e.g. TPE, Thermoplastics) | Metal (e.g. Aluminum) Synthetic material(e.g. TPE, Thermoplastics) | Same |
| Material used for directpatient contact | Textile Polyurethane, PVC, Hydrogel | Textile Polyurethane, TPE, Hydrogel | Similar - the materials used for direct patientcontact are the same as the C2HS with theexception of the TPE material used in theI8000 plus temperature probes. This materialwas tested and found to be biocompatible forthe intended use. |
| Biocompatibility | According to ISO 10993 | Same as C2HS | Same |
| Components | |||
| hand ports | Yes | Yes | |
| iris ports, | Yes | Yes | |
| access panel | Yes | Yes | |
| serial port, | Yes | Yes | |
| trolley with height ad-justment, castor wheelswith brakes & powerreceptacle | Yes | Yes | |
| skin temperature probes,probe covers | Yes | Yes | |
| Oxygen, & air filter inlets | Yes | Yes | |
| sensor module | Yes | Yes | |
| hose grommets | Yes | Yes | |
| accessory rail and cablewrap | Yes | Yes | |
| Thermonitoring | N/A - only displays skin temperature | Trend display of difference betweencentral and peripheral skin temperatures | Similar. Skin temperature is displayed foruser in both systems. Isolette 8000 plusprovides additional temperature trendinformation. |
{5}------------------------------------------------
{6}------------------------------------------------
{7}------------------------------------------------
{8}------------------------------------------------
{9}------------------------------------------------
{10}------------------------------------------------
{11}------------------------------------------------
{12}------------------------------------------------
{13}------------------------------------------------
Discussion of Non-clinical Testing
The Isolette 8000 plus was tested in accordance with applicable standards, quidance and internal design control procedures including performance testing, functional/operation and validation, biocompatibility, human factors, risk analysis and verification of risk control measures. Testing included accessories and optional components.
The following performance data were provided in accordance with standards or technical system requirements and as identified in the IFU Technical Data Section:
Electrical safety and electromagnetic compatibility (EMC), incl. performance testing
Electrical safety and EMC testing were conducted on the Isolette 8000 plus. The device complies with the IEC 60601-1, IEC 60601-2-19, standards for safety and performance and the IEC 60601-1-2 standard for EMC.
Software Verification and Validation Testing
Software verification and validation testing were conducted and documentation was provided as recommended by FDA's Guidance for Industry and FDA Staff, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices."2005. The software for this device was considered as a "major" level of concern, since a failure or latent flaw in the software could directly result in serious injury or death to the patient or operator.
Biocompatibility testing
The biocompatibility evaluation for the Isolette 8000 plus was conducted in accordance with the FDA quidance on Biocompatibility on the International Standard ISO-10993, 'Biological Evaluation of Medical Devices Part 1: Evaluation and Testing, ', and International Standard ISO 10993-1 Biological Evaluation of edical evices Part 1: Evaluation and Testing Within a Risk Manaqement Process," as recognized by FDA. Testing included the following tests:
- Integral Test for volatile organic compounds
- Photogenic bacteria test
- Emission of particles
- Material characterization according to ISO 10993-18
- _ Toxicological Evaluation according to ISO 10993-17
- Cytotoxicity
- Irritation
- _Sensitization
Human Factor
The usability evaluation for the Isolette 8000 plus was conducted in accordance with the FDA quidance: Applying Human Factors and Usability Engineering to Medical Devices Guidance for Industry and Food and Drug Administration Staff, 2016.
Reprocessing
The Isolette 8000 plus was assessed in accordance with the FDA guidance: Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling; Guidance for Industry and Food and Drug Administration Staff, 2015.
Cleaning/Disinfection
Macroscopic and microbiological validation with Oxycide was performed by an accredited laboratory pursuant to DIN EN ISO/IEC 17025 and provided in the submission.
Kangaroo Mode
Kangaroo Care is commonly used in neonatal care to allow skin to skin contact between the parent careqiver. In kangaroo mode, the patient is warmed by the parents or caregivers body heat instead of the device. The patient is removed from the incubator and placed on the caregivers naked breast. To prevent heat loss, the patient may also be covered with a blanket. Skin temperature probes remain on the patient during Kangaroo Mode and function the same as if the patient were inside the incubator. Numerous studies have documented the clear benefits of this simple technique on the physiologic and emotional well-being of infants and mothers, especially for preterm babies. Kangaroo Mode performance testing was performed according to the technical requirements of the Isolette 8000 Plus incubator and provided in the submission.
{14}------------------------------------------------
Animal Study
No animal study has been conducted.
Clinical Studies None
Sterilization
Not applicable
Humidification System (Optional)
Autohumidity performance testing was performed according to the technical requirements of the Isolette 8000 Plus incubator and provided in the submission.
Thermomonitoring
Thermomonitoring performance testing was performed according to the technical requirements of the Isolette 8000 Plus incubator and provided in the submission.
External Communication
Serial data output or Medibus X performance testing was performed according to the technical requirements of the Isolette 8000 Plus incubator and provided in the submission.
Trendelenburg (Tilt Mechanism)
Regression testing was performed for a mechanical change to the tilt mechanism from the predicate to the Isolette 8000 plus according to the technical requirements and provide in the submission.
Conclusion Drawn from Non-Clinical Studies
The results of the non-clinical bench testing, and comparison to the predicate device show that the Isolette® 8000 plus meets the performance requirements of the standards and guidance mentioned above and is substantially equivalent to the predicate device K001242.
§ 880.5400 Neonatal incubator.
(a)
Identification. A neonatal incubator is a device consisting of a rigid boxlike enclosure in which an infant may be kept in a controlled environment for medical care. The device may include an AC-powered heater, a fan to circulate the warmed air, a container for water to add humidity, a control valve through which oxygen may be added, and access ports for nursing care.(b)
Classification. Class II (performance standards).